SLDE trades 49.2% below Wall Street's consensus target of $31.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes SLDE achieves its forward estimates and maintains a stable P/E multiple of 5.9x. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Slide Insurance Holdings, Inc. Common Stock (SLDE) has a Wall Street consensus price target of $31.00, based on estimates from 4 covering analysts. With the stock currently trading at $20.78, this represents a potential upside of +49.2%. The company has a market capitalization of $2.38B.
Analyst price targets range from a low of $31.00 to a high of $31.00, representing a 0% spread in expectations. The median target of $31.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, SLDE trades at a trailing P/E of 6.2x and forward P/E of 5.9x. Analysts expect EPS to grow -1.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $29.25, with bear and bull scenarios of $18.43 and $38.54 respectively. Model confidence stands at 57/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
HCIHCI Group, Inc. | $2.3B | $180.41 | $126.50 | -29.9% | Buy | 10.4x | 14 |
UPCUniverse Pharmaceuticals Inc. | $4M | $6.32 | — | — | — | — | — |
HRTGHeritage Insurance Holdings, Inc. | $826M | $27.20 | $36.00 | +32.4% | Buy | 6.3x | 9 |
ALLThe Allstate Corporation | $64.7B | $251.46 | $250.00 | -0.6% | Hold | 8.3x | 44 |
TRVThe Travelers Companies, Inc. | $73.1B | $343.73 | $310.40 | -9.7% | Hold | 12.2x | 43 |
CBChubb Limited | $139.4B | $359.30 | $346.75 | -3.5% | Buy | 13.3x | 43 |
UNMUnum Group | $14.4B | $89.20 | $98.33 | +10.2% | Hold | 10.2x | 30 |
CINFCincinnati Financial Corporation | $29.4B | $189.06 | $182.50 | -3.5% | Buy | 21.8x | 17 |
WRBW. R. Berkley Corporation | $26.6B | $71.54 | $69.10 | -3.4% | Hold | 15.3x | 30 |
RNRRenaissanceRe Holdings Ltd. | $13.8B | $323.69 | $310.75 | -4.0% | Hold | 7.9x | 28 |
Quick answers to the most common questions about buying SLDE stock.
The consensus Wall Street price target for SLDE is $31, representing 49.2% upside from the current price of $20.78. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
SLDE has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is predominantly bullish, with 4 Buy/Strong Buy ratings. The consensus 12-month price target of $31 implies 49.2% upside from current levels.
With a forward P/E of 5.8805x, SLDE trades at a relatively low valuation. The consensus target of $31 implies 49.2% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $31 for SLDE, while the most conservative target is $31. The consensus of $31 represents the median expectation. Our quantitative valuation model projects a bull case target of $39 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
SLDE is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month SLDE stock forecast based on 4 Wall Street analysts shows a consensus price target of $31, with estimates ranging from $31 (bear case) to $31 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $29, with bear/bull scenarios of $18/$39.
Our quantitative valuation model calculates SLDE's fair value at $29 (base case), with a bear case of $18 and bull case of $39. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 57/100.
SLDE trades at a forward P/E ratio of 5.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 6.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on SLDE, with a "Buy" consensus rating and $31 price target (49.2% upside). 4 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
SLDE analyst price targets range from $31 to $31, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $31 consensus represents the middle ground. Our model's $18-$39 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.